We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


BMG LABTECH to Hold a Cell Based Assays Users Group Meeting

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BMG LABTECH to Hold a Cell Based Assays Users Group Meeting"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cell based, biologically relevant assays are advancing at an unprecedented rate and their robustness is becoming more essential to everyone working in this field.

BMG LABTECH is holding a Cell Based Assays User Group Meeting on December 6th at the John Radcliffe Hospital, Oxford. If users are currently performing cell based assays or are planning to start a new project in this area join us for an afternoon of interesting presentations highlighting new and innovative techniques in this field.

BMG LABTECH invite users and their colleagues to learn more about new and novel cell based assay technologies with a range of academic and commercial speakers who will present on the application of the latest advances in this area.

Here users will have the opportunity to meet with other scientists working in their field and hear presentations about methods, techniques and applications of new technologies.

Speakers from:
• Luxcel Biosciences
• CellAura Technologies
• DiscoveRx
• Paterson Institute
• Oxford University

BMG LABTECH will be highlighting the FLUOstar Omega with ACU and the well scanning capabilities of the PHERAstar FS.

The FLUOstar Omega and ACU provides a true ‘walk away solution’ for users long term cell based assays, it avoids the need to transfer plates from incubators to the reader thus saves user intervention time and maintains their experimental conditions by avoiding exposing cells to the atmosphere.

The ACU and Omega combination is good for many cell based assays including migration and proliferation but is especially designed for those assays where hypoxia or ischemia/reperfusion is being investigated.